Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

Fig. 3

Variation and DNA methylation of EFNA family in pan-cancer. A Alteration frequency of EFNAs across various cancers was analyzed by cBioPortal. B Alterations of CNV of EFNAs in cancers were assessed from GSCA. C Correlations between DNA methylation and mRNA expression of EFNAs were determined by TCGA. D The methylation difference between tumor and para-cancer paired samples, and the gray dots indicated no statistical significance. *p < 0.05, **p < 0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us